Transcriptional and functional consequences of Oncostatin M signaling on young Dnmt3a-mutant hematopoietic stem cells
Logan S. Schwartz(Tufts University), Jennifer J. Trowbridge(Jackson Laboratory)
Cited by 14
Related Papers
Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis
|Leukemia|2019|128
Challenges and opportunities for modeling aging and cancer
|Cancer Cell|2023|24
Metformin reduces the clonal fitness of Dnmt3aR878H hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic state
|Research Square|2024|5
Oncostatin M is a Master Regulator of an Inflammatory Network in <i>Dnmt3a</i> -Mutant Hematopoietic Stem Cells
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1